3 March 2022 in Nature Biotechnology
14 August 2019 in Nature Communications
Anaerobic bacteria represent an overlooked rich source of biological and chemical diversity. Due to the challenge of cultivation and genetic intractability, assessing the capability of their biosynthetic gene clusters (BGCs) for secondary metabolite production requires an efficient heterologous expression system. However, this kind of host system is still unavailable. Here, we use the facultative anaerobe Streptococcus mutans UA159 as a heterologous host for the expression of BGCs from anaerobic bacteria. A natural competence based large DNA fragment cloning (NabLC) technique was developed, which can move DNA fragments up to 40-kb directly and integrate a 73.7-kb BGC to the genome of S. mutans UA159 via three rounds of NabLC cloning. Using this system, we identify an anti-infiltration compound, mutanocyclin, from undefined BGCs from human oral bacteria. We anticipate this host system will be useful for heterologous expression of BGCs from anaerobic bacteria.
26 February 2018 in Proceedings of the National Academy of Sciences
Seven-carbon-chain–containing sugars exist in several groups of important bacterial natural products. Septacidin represents a group of l-heptopyranoses containing nucleoside antibiotics with antitumor, antifungal, and pain-relief activities. Hygromycin B, an aminoglycoside anthelmintic agent used in swine and poultry farming, represents a group of d-heptopyranoses–containing antibiotics. To date, very little is known about the biosynthesis of these compounds. Here we sequenced the genome of the septacidin producer and identified the septacidin gene cluster by heterologous expression. After determining the boundaries of the septacidin gene cluster, we studied septacidin biosynthesis by in vivo and in vitro experiments and discovered that SepB, SepL, and SepC can convert d-sedoheptulose-7-phosphate (S-7-P) to ADP-l-glycero-β-d-manno-heptose, exemplifying the involvement of ADP-sugar in microbial natural product biosynthesis. Interestingly, septacidin, a secondary metabolite from a gram-positive bacterium, shares the same ADP-heptose biosynthesis pathway with the gram-negative bacterium LPS. In addition, two acyltransferase-encoding genes sepD and sepH, were proposed to be involved in septacidin side-chain formation according to the intermediates accumulated in their mutants. In hygromycin B biosynthesis, an isomerase HygP can recognize S-7-P and convert it to ADP-d-glycero-β-d-altro-heptose together with GmhA and HldE, two enzymes from the Escherichia coli LPS heptose biosynthetic pathway, suggesting that the d-heptopyranose moiety of hygromycin B is also derived from S-7-P. Unlike the other S-7-P isomerases, HygP catalyzes consecutive isomerizations and controls the stereochemistry of both C2 and C3 positions. Significance Septacidin and its analogs are potential anticancer and pain-relief drugs. Hygromycin B is an anthelmintic agent practically used in swine and poultry farming. A common feature of these compounds is that they all have heptose moieties. Here we show that the heptoses of septacidin and hygromycin B are both derived from d-sedoheptulose-7-phosphate but are biosynthesized through different pathways. Septacidin producer, a gram-positive bacterium, shares the same ADP-heptose biosynthesis pathway with gram-negative bacterium lipopolysaccharide biosynthesis. These findings not only elucidate the biosynthesis mechanisms of septacidin and hygromycin B but enable opportunities for manipulation of their heptose moieties by combinatorial biosynthesis and for changing the structure of heptoses in gram-negative bacterium lipopolysaccharides.
12 January 2016 in Applied Microbiology and Biotechnology
5 December 2018 in Journal of the American Chemical Society
26 February 2015 in Angewandte Chemie International Edition